Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 2, 2012, Pages 173-178

  Hashino, S ^a   Morita, L ^a   Kanamori, H ^a   Takahata, M ^a   Onozawa, M ^a   Nakagawa, M ^a   Kawamura, T ^a   Fujisawa, F ^a   Kahata, K ^a   Izumiyama, K ^a   Yonezumi, M ^a   Chiba, K ^a   Kondo, T ^a   Asaka, M ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFOTIAM; CEFOZOPRAN; CEFTAZIDIME; COLONY STIMULATING FACTOR 1; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; OFLOXACIN; PANIPENEM PLUS BETAMIPRON; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BURKHOLDERIA CEPACIA; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG ERUPTION; ENTEROCOCCUS FAECIUM; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEART PALPITATION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NAUSEA; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS HAEMOLYTICUS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; JAPAN; MALE; MIDDLE AGED; NEUTROPENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857044082     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1290-2     Document Type: Article

References (22)

1. M Yoshida K Tsubaki T Kobayashi, et al. 1999 Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991 Int J Hematol 70 261 267 10643152 1:STN:280:DC%2BD3c7gslOltg%3D%3D
2. GP Bodey L Jadeja L Elting, et al. 1985 Pseudomonas bacteremia. Retrospective analysis of 410 episodes Arch Intern Med 145 1621 1629 3927867 10.1001/archinte.1985.00360090089015 1:STN:280:DyaL2M3nvVGnug%3D%3D (Pubitemid 16258204)
3. WT Hughes D Armstrong GP Bodey, et al. 1997 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America Clin Infect Dis 25 551 573 9314442 10.1086/513764 1:STN:280:DyaK2svlvVWisQ%3D%3D (Pubitemid 127774275)
4. T Masaoka 1998 Management of fever of unknown origin in the neutropenic patient: the Japanese experience Int J Hematol 68 Supp 1 S9 S11 9838737 1:CAS:528:DyaK1MXlt1Sn
5. H Shibata T Yamane E Sakamoto, et al. 2005 Clinical analysis of antibiotic treatment for febrile neutropenia Jpn J Antibiot 58 382 387 16276739 (Pubitemid 41355455)
6. WT Hughes D Armstrong GP Bodey, et al. 2002 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 730 751 11850858 10.1086/339215 (Pubitemid 34194843)
7. K Tamura K Imajo N Akiyama, et al. 2004 Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia Clin Infect Dis 39 Suppl 1 S15 S24 15250016 10.1086/383046 1:CAS:528:DC%2BD2cXntVahs78%3D (Pubitemid 38971471)
8. A Sandiumenge J Rello 2003 Cyclic rotation of antibiotics. Is all that glitters gold? Enferm Infecc Microbiol Clin 21 93 100 12586033 10.1157/13042866 (Pubitemid 36285846)
9. DP Raymond SJ Pelletier TD Crabtree, et al. 2001 Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit Crit Care Med 29 1101 1108 11395583 10.1097/00003246-200106000-00001 1:STN:280:DC%2BD3MzislOjug%3D%3D (Pubitemid 32554319)
10. A Gafter-Gvili A Fraser M Paul, et al. 2005 Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients Ann Intern Med 142 979 995 15968013 (Pubitemid 40840313)
11. J Pascoe N Steven 2009 Antibiotics for the prevention of febrile neutropenia Curr Opin Hematol 16 48 52 19057204 10.1097/MOH.0b013e32831ac543 1:CAS:528:DC%2BD1cXhsVKnu7%2FF
12. Y Chong H Yakushiji T Kamimura 2011 Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies Int J Infect Dis 15 e277 e281 21324723 10.1016/j.ijid.2010.12.010 1:CAS:528: DC%2BC3MXjs1Wrtrg%3D
13. JP Donnelly G Maschmeyer S Daenen 1992 Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group Eur J Cancer 28A 873 878 1524913 10.1016/0959-8049(92)90138-R 1:STN:280: DyaK38zpvFSrsA%3D%3D
14. V Krcméry Jr S Spanik I Krupova, et al. 1998 Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study J Chemother 10 320 325 9720472 (Pubitemid 28372366)
15. HV Baum U Franz HK Geiss 2000 Prevalence of ciprofloxacin-resistant Escherichia coli in hematologic-oncologic patients Infection 28 278 281 11073133 10.1007/s150100070019 1:STN:280:DC%2BD3crhsVWrsw%3D%3D
16. C Solano A Gutierrez F Martinez, et al. 2005 Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin-tazobactam Bone Marrow Transplant 36 59 65 15908979 10.1038/sj.bmt.1705005 1:CAS:528:DC%2BD2MXltlSrtbo%3D (Pubitemid 40946051)
17. M Paul D Yahav A Fraser, et al. 2006 Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials J Antimicrob Chemother 57 176 189 16344285 10.1093/jac/dki448 1:CAS:528:DC%2BD28XovVGgug%3D%3D (Pubitemid 43160156)
18. [No authors listed] 1990 From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel J Infect Dis 161 397 401 10.1093/infdis/161.3.397
19. R Feld M Paesmans AG Freifeld, et al. 2002 Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies Clin Infect Dis 35 1463 1468 12471564 10.1086/344650 (Pubitemid 36020688)
20. F Takaku K Nagai T Maekawa, et al. 1984 Criteria for the estimation of clinical effect of antimicrobial drugs in the treatment of infections associated with granulocytopenia Rinsho Ketsueki 25 588 592 6471442 1:STN:280: DyaL2c3pt12htA%3D%3D
21. EJ Bow C Rotstein GA Noskin, et al. 2006 A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin- tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies Clin Infect Dis 43 447 459 16838234 10.1086/505393 1:CAS:528:DC%2BD28XovFWgs7o%3D (Pubitemid 44157153)
22. DJ Winston HM Lazarus RA Beveridge, et al. 2001 Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients Clin Infect Dis 32 381 390 11170945 10.1086/318500 1:CAS:528:DC%2BD3MXhs1Whurw%3D (Pubitemid 32173623)